CAS: 7463-31-2; 3-Acetamidoacetophenone

该化合物是其氨化功能组的有机化合物,其特征是附在苯环上的乙酰组,该组又被乙酰组替代,该组在室温中一般是固体,在乙醇和丙酮等有机溶剂中可溶解,但由于其缺水芳香结构,水中的溶解性可能有限.乙酰胺和氨化物的功能都表明在制药和有机合成中,特别是在开发止痛剂或抗炎剂方面的潜在应用.其分子结构允许各种相互作用,包括氢联结,这可能影响其再活性和生物活动.与许多有机化合物一样,处理应谨慎进行,考虑到潜在的毒性和环境影响.建议在实验室环境中与该物质打交道时采取适当的安全措施,包括使用个人防护设备.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号108-24-7 乙酸酐 | CAS号99-03-6 3'-氨基苯乙酮 | CAS号75-36-5 乙酰氯 | CAS号64-19-7 冰醋酸 | CAS号98-86-2 苯乙酮 | CAS号121-89-1 3-硝基苯乙酮 | CAS号201230-82-2 carbon monoxide | CAS号5369-16-4 3-异丙基苯胺 | CAS号325715-13-7 N-(3-乙酰基苯基)-N-甲基乙酰胺 | CAS号30095-56-8 3-乙酰氨基-2-溴苯乙酮 | CAS号96605-66-2 N-乙基-N-3-[(3-二甲... | CAS号587-02-0 3-乙基苯胺 | CAS号159724-49-9 Ethanone,1-(2,3... | CAS号115931-01-6 N-[3-(3-氰基吡唑并[1... | CAS号16994-13-1 1-(5-氨基-2-硝基苯基)乙酮 | CAS号18640-60-3 1-(5-氯-2-硝基)苯乙酮 | CAS号7766-63-4 N-(3-propan-2-y...

合成工艺路线路线简述

    苯乙酮置于硫酸,硝酸,铁粉体系中,化学反应 2.0H,反应生成 3-乙酰胺基苯乙酮
    参考文献:一种合成扎莱普隆的新方法
    标题:一种合成扎莱普隆的新方法
    摘要:本发明提供了一种合成扎莱普隆的新方法.具体地,本发明方法以苯乙酮为原料,制得n-乙基-N-[3-(3-二甲基胺-1-氧代-2-丙烯基)苯基]乙酰胺,再与3-氨基-4-氰基吡唑反应,形成n-[3-(3-氰基吡唑并[1,5-α]嘧啶-7-基)苯基]-N-乙基乙酰胺.本发明的合成路线步骤少,后处理简单,成本低廉,适宜于产业化生产.

    海关参考信息

    专利信息


    专利号:US-2005119332-A1
    优先权日:1998-03-12
    标 题 :Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
    发明人:JEPPESEN LONE; ANDERSEN HENRIK S; OLSEN OLE H; JUDGE LUKE M; HOLSWORTH DANIEL D; BAKIR FARID; AXE FRANK U; GE YU
    摘要:The present invention provides novel compounds of formula 1a, n nnovel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

    专利号:US-2002165398-A1
    优先权日:1998-03-12
    标题:Modulators of protein tyrosine phosphatases (PTPases)
    发明人:JEPPESEN LONE; ANDERSEN HENRIK SUNE; OLSEN OLE HVILSTED; JUDGE LUKE MILBURN; HOLSWORTH DANIEL DALE; BAKIR FARID; AXE FRANK URBAN; GE YU
    摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. n The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimers disease and schizophrenia, and infectious diseases.

    专利号:US-2022356182-A1
    优先权日:2009-03-27
    标题 :Inhibitors of hepatitis c virus replication
    发明人:COBURN CRAIG A; LUDMERER STEVEN W; LIU KUN; WU HAO; SOLL RICHARD; ZHONG BIN; ZHU JIAN
    权利人:MERCK SHARP & DOHME
    摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

    专利号:US-7034154-B2
    优先权日:1999-08-10
    标 题:Synthesis of substituted pyrazolopyrimidines
    发明人:GROSS RAYMOND S; WILCOXEN KEITH M; OGLESBY RICHARD CHRISTOPHER
    权利人:NEUROCRINE BIOSCIENCES INC
    摘要:Methods of making substituted pyrazolopyrimidines generally and, more particularly, N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide. Such compounds have utility over a wide range of indications, including treatment of insomnia. In the practice of the present invention, improved techniques which do not require use and/or isolation of the pyrazole intermediate are disclosed, as well as improved techniques for making the reaction intermediates themselves. Such techniques offer significant advantages, including enhanced efficiency, particularly in the context of large scale manufacture.

    专利号:US-7498434-B2
    优先权日:2004-01-14
    标题:Two-phase method for the synthesis of selected pyrazolopyrimidines
    发明人:CANTRELL GARY LEE; MOSER FRANK WILLIAM; HALVACHS ROBERT EDWARD
    权利人:MALLINCKRODT INC
    摘要:An improved method of making a substituted pyrazolopyrimidine. The method comprises reacting a aminopyrazole compound or a salt thereof with a substituted 1-oxo-2-propenyl-arene(-heterocycle) or a salt thereof under acidic conditions in a reaction medium including a two-phase mixture of an aqueous solution and a water-immiscible organic liquid. Specific substituted pyrazolopyrimidines include N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide and N-methyl-N-(3-{3-[2-thienyl-carbonyl]-pyrazolo[1,5-a]-pyrimidin-7-yl}phenyl)acetamide.

    专利号:US-11053243-B2
    优先权日:2009-03-27
    标 题:Inhibitors of hepatitis C virus replication
    发明人:COBURN CRAIG A; LUDMERER STEVEN W; LIU KUN; WU HAO; SOIL RICHARD; ZHONG BIN; ZHU JIAN
    权利人:MERCK SHARP & DOHME
    摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
    浙江海翔药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hisoar.com
    电话: 0576-89088179👤
    📞浙江海翔药业股份有限公司 ⚠️参考联系方式

    销售电话:0576-89088179
    邮箱:info@hisoar.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海灏云化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.haoyunchem.com
    企业联系电话:021-68367562,68369562,15002147577👤
    📞上海灏云化工科技有限公司 ⚠️参考联系方式
    联系人:宋先生
    电话:021-68367562,68369562,15002147577
    手机:15002147577
    传真:021-68369562
    邮箱:sales@haoyunchem.com,info@haoyunchem.com
    通信地址: 上海市浦东新区沈梅路123弄3号楼808室
    邮编: 201318
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区沈梅路123弄3号楼808室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1021/jm301793a
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知